Cutoff values of the Inflammatory Bowel Disease Questionnaire to predict a normal health related quality of life

Journal of Crohn's and Colitis

Volumn 4, Issue 6, 2010, Pages 637-641

  Huaman J W ^a   Casellas, F ^a   Borruel, N ^a   Pelaez A ^a   Torrejon A ^a   Castells, I ^a   Masachs, M ^a   Varela, E ^a   Guarner, F ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Crohn's disease; Cutoff value; Quality of life; Ulcerative colitis

Indexed keywords

ADULT; ARTICLE; CALCULATION; CROHN DISEASE; ENTERITIS; FEMALE; HUMAN; IBD QUESTIONNAIRE 36; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; ULCERATIVE COLITIS;

ADULT; COLITIS, ULCERATIVE; CROHN DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS INDICATORS; HUMANS; INFLAMMATORY BOWEL DISEASES; LINEAR MODELS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; ROC CURVE; SPAIN;

EID: 78649509328     PISSN: 18739946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crohns.2010.07.006     Document Type: Article

References (24)

1. O'Morain C., Tobin A., Leen E., Suzuki Y., O'Riordan T. Criteria of case definition in Crohn's disease and ulcerative colitis. Scand J Gastroenterol Suppl 1989, 170:7-11.
2. Loftus E.V. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004, 126:1504-1517.
3. Pajares J.M., Gisbert J.P. Epidemiology of inflammatory bowel disease in Spain. A systematic review. Rev Enferm Dig 2001, 93:15-20.
4. Bernklev T., Jahnsen J., Henriksen M., Lygren I., Aadland E., Sauar J., Schulz T., Stray N., Vatn M., Moum B. Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis 2006, 12:402-412.
5. Vergara M., Casellas F., Badia X., Malagelada J.R. Assessing the quality of life of household members of patients with inflammatory bowel disease: development and validation of a specific questionnaire. Am J Gastroenterol 2002, 97:1429-1437.
6. Casellas F., Arenas J.I., Baudet J.S., Fabregas S., Garcia N., Gelabert J., Medina C., Ochotorena I., Papo M., Rodrigo L., Malagelada J.R. Impairment of health-related quality of life in patients with inflammatory bowel disease: a Spanish multicenter study. Inflamm Bowel Dis 2005, 11:488-496.
7. Fuller-Thomson E., Sulman J. Depression an inflammatory bowel disease: findings from two nationally representative Canadian surveys. Inflamm Bowel Dis 2006, 12:697-707.
8. The WHOQOL Group The World Health Organization Quality of Life assessment: position paper from the World Health Organization. Soc Sci Med 1995, 41:1403.
9. Guyatt G., Mitchell A., Irvine E.J., Singer J., Williams N., Goodacre R., Tompkins C. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989, 96:804-810.
10. Love J.R., Irvine E.J., Fedorak R.N. Quality of life in inflammatory bowel disease. J Clin Invest 1992, 14:15-19.
11. Drossman D.A., Patrick D.L., Mitchell C.M., Zagami E.A., Appelbaum M.I. Health-related quality of life in inflammatory bowel disease. Functional status and patient worries and concerns. Dig Dis Sci 1989, 34:1379-1386.
12. Otley A., Smith C., Nicholas D., Avolio J., Sherman P.M., Griffiths A.M. The IMPACT questionnaire: a valid measure of health-related quality of life in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2002, 35:557-563.
13. Farmer R.G., Wasley K.A., Farmer J.M. Quality of life assessment by patients with inflammatory bowel disease. Cleve Clin J Med 1992, 59:35-42.
14. König H.H., Ulshöfer A., Gregor M., von Tirpitz C., Reinshagen M., Adler G., Leidl R. Validation of the EuroQol questionnaire in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 2002, 14:1205-1215.
15. Sandborn W.J., Feagan B.G., Hanauer S.B., Lochs H., Löfberg R., Modigliani R., Present D.H., Rutgeerts P., Schölmerich J., Stange E.F., Sutherland L.R. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterology 2002, 122:512-530.
16. D'Haens G., Sandborn W.J., Feagan B.G., Geboes K., Hanauer S.B., Irvine E.J., Lémann M., Marteau P., Rutgeerts P., Schölmerich J., Sutherland L.R. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology 2007, 132:763-786.
17. Hlavaty T., Persoons P., Vermeire S., Ferrante M., Pierik M., Van Assche G., Rutgeerts P. Evaluation of short-term responsiveness and cutoff values of inflammatory bowel disease questionnaire in Crohn's disease. Inflamm Bowel Dis 2006, 12:199-204.
18. Higgins P.D., Schwartz M., Mapili J., Krokos I., Leung J., Zimmermann E.M. Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitis. Gut 2005, 546:782-788.
19. López-Vivancos J., Casellas F., Badia X., Vilaseca J., Malagelada J.R. Validation of the Spanish version of the Inflammatory Bowel Disease Questionnaire on ulcerative colitis and Crohn's disease. Digestion 1999, 60:274-280.
20. Badia X., Fernández E., Segura A. Influence of sociodemographic and health status variables on evaluation of health states in a Spanish population. Eur J Public Health 1995, 5:87-93.
21. Badia X., Roset M., Montserrat S., Herdman M., Segura A. The Spanish version of EuroQol: a description and its applications. European Quality of Life scale. Med Clin (Barc) 1999, 112(Suppl 1):79-85.
22. Masachs M., Casellas F., Malagelada J.R. Spanish translation, adaptation, and validation of the 32-item questionnaire on quality of life for inflammatory bowel disease (IBDQ-32). Rev Esp Enferm Dig 2007, 99:511-519.
23. Book chapter 4.4 "L'estat de salut i la qualitat de vida". Pla de salut de Catalunya a l'horitzó 2010. Direcció General de Planificació i Avaluació Eds. First ed. 2009;77-107. ISBN: 978-84-393-7963-8.
24. Casellas F., López-Vivancos J., Casado A., Malagelada J.-R. Factors affecting health related quality of life of patients with inflammatory bowel disease. Qual Life Res 2002, 11:775-781.